References
- Suhr OB. Commentary to Isabel Conceicao et al. early diagnosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26:1–2.
- Conceicao I, Damy T, Romero M, et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26:3–9.
- Koike H, Nishi R, Ikeda S, et al. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: an ultrastructural study. J Neurol Sci. 2018;394:99–106.
- Bergstrom J, Gustavsson A, Hellman U, et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol. 2005;206:224–232.
- Pilebro B, Suhr OB, Naslund U, et al. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci. 2016;121:17–24.
- Suhr OB, Wixner J, Anan I, et al. Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families. PLoS One. 2019;14:e0211983.
- Coutinho MCA, Cortez-Dias N, Goncalves S, et al. How useful is 99mTc-DPD scintigraphy in diagnosis of cardiac amyloidosis in transthyretin V30M familial amyloid polyneuropathy? J Am Coll Cardiol. 2017;69:1423.
- Arvidsson S, Pilebro B, Westermark P, et al. Amyloid cardiomyopathy in hereditary transthyretin V30M amyloidosis—impact of sex and amyloid fibril composition. PLoS One. 2015;10:e0143456.